Catherine M. Szyman - Jun 15, 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Jun 15, 2021
Transactions value $: -$268,992
Form type: 4
Date filed: 6/15/2021, 08:33 PM
Previous filing: Jun 4, 2021
Next filing: Aug 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$76K	+3.41K	+12.31%	$22.29	31.1K	Jun 15, 2021	Direct	F1
transaction	EW	Common Stock	Sale	-$345K	-3.41K	-10.96%	$101.17	27.7K	Jun 15, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-3.41K	-100%	$0.00^*	0	Jun 15, 2021	Common Stock	3.41K	$22.29	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.